Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex)
NCT ID: NCT04768595
Last Updated: 2021-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
56 participants
INTERVENTIONAL
2021-03-03
2021-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bioavailability of Omega-3 Fatty Acids From Fish Oil Supplements
NCT06665464
Metabolic Actions of Omega-3 Fatty Acids
NCT01896414
Omega-3 Supplement and Health Markers
NCT06492694
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance
NCT03259412
Omega-3 Fatty Acids and Insulin Sensitivity
NCT01686568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
1g corn oil capsules
Placebo
Two, 1g capsules taken daily with food
Ceto 10
1g capsules containing oil from north atlantic fish containing broad spectrum marine oil.
Ceto 10
Two, 1g capsules daily with food
Omega-3
1 g capsules containing traditional, commericially available omega-3 marine oil.
Fish oil
Two, 1g capsules daily with food
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
Two, 1g capsules taken daily with food
Ceto 10
Two, 1g capsules daily with food
Fish oil
Two, 1g capsules daily with food
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Willing to refrain from taking omega-3 supplements for 1 month prior to study start
3. Willing to take study supplement for 2 months
Exclusion Criteria
2. Subjects known to be pregnant or breast feeding
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Møreforsking AS
OTHER
Epax Norway AS
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa Midtbø, PhD
Role: PRINCIPAL_INVESTIGATOR
Møreforsking AS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Møreforsking AS
Ålesund, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Lisa Midtbø
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P2008
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.